JKB Financial Services Ltd.

As on : 14-Aug-2025

Hot Pursuit
14-Aug-2025 10:09

Pfizer jumps after robust Q1 earnings

On a standalone basis, net profit rose 27.23% year-on-year to Rs 191.75 crore in Q1 FY26 from Rs 150.71 crore in Q1 FY25, but fell 3.3% sequentially from adjusted net profit of Rs 198.33 crore in Q4 FY25.

Revenue from operations stood at Rs 603.05 crore, up 7.14% YoY from Rs 562.86 crore and 1.88% higher than Rs 591.91 crore in the March quarter.

Profit before tax and exceptional items stood at Rs 259.53 crore in Q1 FY26, up 28.09% YoY and up 2.59% from Rs 252.99 crore in Q4 FY25.

Total expenditure rose 1.99% YoY to Rs 393.03 crore from Rs 385.37 crore and was up 7.86% sequentially from Rs 364.41 crore. Cost of material consumed jumped 53.60% YoY to Rs 88.69 crore in Q1 FY26.

Pfizer is one of the world's leading pharmaceutical companies, specialising in four key business categories ' vaccines, hospitals, internal medicine, and inflammation & immunology.

GET IN TOUCH